These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7004444)

  • 1. Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides.
    Llorens C; Gacel G; Swerts JP; Perdrisot R; Fournie-Zaluski MC; Schwartz JC; Roques BP
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1710-6. PubMed ID: 7004444
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory potency of various peptides on enkephalinase activity from mouse striatum.
    Fournie-Zaluski MC; Perdrisot R; Gacel G; Swerts JP; Roques BP; Schwartz JC
    Biochem Biophys Res Commun; 1979 Nov; 91(1):130-5. PubMed ID: 518615
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of various enkephalin analogs and dipeptides on the enzymatic activity of enkephalinase B isolated from calf-brain striatum.
    van Amsterdam JG; van Buuren KJ; Koomen AP; Soudijn W
    Life Sci; 1986 Mar; 38(12):1111-8. PubMed ID: 3515091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of calf-brain enkephalinase A and B.
    van Amsterdam JG; van Buuren KJ; de Jong AM; Soudijn W
    Life Sci; 1983; 33 Suppl 1():109-12. PubMed ID: 6363851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enkephalinase: selective inhibitors and partial characterization.
    Sullivan S; Akil H; Blacker D; Barchas JD
    Peptides; 1980; 1(1):31-5. PubMed ID: 6264406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
    Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W
    Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of porcine kidney "enkephalinase" by substituted-N-carboxymethyl dipeptides.
    Mumford RA; Zimmerman M; ten Broeke J; Taub D; Joshua H; Rothrock JW; Hirshfield JM; Springer JP; Patchett AA
    Biochem Biophys Res Commun; 1982 Dec; 109(4):1303-9. PubMed ID: 6762880
    [No Abstract]   [Full Text] [Related]  

  • 10. Phosphoryl-Leu-Phe: a potent inhibitor of the degradation of enkephalin by enkephalinase.
    Altstein M; Blumberg S; Vogel Z
    Eur J Pharmacol; 1981 Dec; 76(2-3):299-300. PubMed ID: 7037430
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors.
    Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP
    Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
    Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
    Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors.
    Fournie-Zaluski MC; Lucas E; Waksman G; Roques BP
    Eur J Biochem; 1984 Mar; 139(2):267-74. PubMed ID: 6321177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enkephalinase: selective peptide inhibitors.
    Hudgin RL; Charleson SE; Zimmerman M; Mumford R; Wood PL
    Life Sci; 1981 Dec; 29(25):2593-601. PubMed ID: 7033704
    [No Abstract]   [Full Text] [Related]  

  • 15. A highly sensitive fluorometric assay for "enkephalinase," a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins.
    Florentin D; Sassi A; Roques BP
    Anal Biochem; 1984 Aug; 141(1):62-9. PubMed ID: 6388410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum.
    van Amsterdam JG; van Buuren KJ; Soudijn W
    Biochem Biophys Res Commun; 1983 Sep; 115(2):632-41. PubMed ID: 6578795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic properties of N-terminal substituted phenylalanyl-alanine.
    Borin G; Giusti P; Cima L
    Life Sci; 1983 Oct; 33(16):1575-80. PubMed ID: 6355734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propioxatins A and B, new enkephalinase B inhibitors. IV. Characterization of the active site of the enzyme using synthetic propioxatin analogues.
    Inaoka Y; Naruto S
    J Biochem; 1988 Nov; 104(5):706-11. PubMed ID: 3069842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase A.
    Chipkin RE; Iorio LC; Barnett A; Berger J; Billard W
    Adv Biochem Psychopharmacol; 1982; 33():235-42. PubMed ID: 6751031
    [No Abstract]   [Full Text] [Related]  

  • 20. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
    Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.